Ligand Pharmaceuticals Inc financial data

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Industry
Pharmaceutical Preparations
Location
3911 Sorrento Valley Blvd, Suite 110, San Diego, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
LIGAND PHARMACEUTICALS (to 9/13/1994)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.7K % +466%
Quick Ratio 130 % +514%
Debt-to-equity 13.1 % -45.8%
Return On Equity 5.71 % +43.4%
Return On Assets 5.05 % +57.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.3M shares +5.27%
Common Stock, Shares, Outstanding 18.1M shares +4.33%
Entity Public Float 900M USD -10%
Common Stock, Value, Issued 19K USD +11.8%
Weighted Average Number of Shares Outstanding, Basic 18M shares +4.35%
Weighted Average Number of Shares Outstanding, Diluted 18M shares +1.68%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 133M USD -25.8%
Research and Development Expense 22.3M USD -30.1%
General and Administrative Expense 59.2M USD -13.2%
Operating Income (Loss) -16.4M USD -467%
Nonoperating Income (Expense) 69.4M USD -23.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 53M USD -44.3%
Income Tax Expense (Benefit) 10.9M USD -79.9%
Net Income (Loss) Attributable to Parent 42.1M USD +55.2%
Earnings Per Share, Basic 2.41 USD/shares +53.5%
Earnings Per Share, Diluted 2.35 USD/shares +63.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.1M USD -36.2%
Accounts Receivable, after Allowance for Credit Loss, Current 37.5M USD +33.9%
Inventory, Net 18.7M USD -30.6%
Other Assets, Current 7.12M USD +157%
Assets, Current 312M USD +12.8%
Deferred Income Tax Assets, Net 190K USD -97.8%
Property, Plant and Equipment, Net 15M USD +31.5%
Operating Lease, Right-of-Use Asset 7.4M USD -35%
Intangible Assets, Net (Excluding Goodwill) 283M USD -13%
Goodwill 105M USD -0.4%
Other Assets, Noncurrent 11.9M USD +165%
Assets 866M USD +14.3%
Accounts Payable, Current 1.79M USD -81.3%
Employee-related Liabilities, Current 2.69M USD +14.6%
Accrued Liabilities, Current 12.2M USD +66.9%
Contract with Customer, Liability, Current 1.2M USD
Liabilities, Current 18.6M USD -36.8%
Contract with Customer, Liability, Noncurrent 14.8M USD
Deferred Income Tax Liabilities, Net 30.1M USD +8.9%
Operating Lease, Liability, Noncurrent 6.42M USD -41.6%
Other Liabilities, Noncurrent 29.4M USD +35.5%
Liabilities 91.2M USD -2.15%
Accumulated Other Comprehensive Income (Loss), Net of Tax -935K USD +3.31%
Retained Earnings (Accumulated Deficit) 537M USD +8.51%
Stockholders' Equity Attributable to Parent 775M USD +16.6%
Liabilities and Equity 866M USD +14.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 18.7M USD -44.8%
Net Cash Provided by (Used in) Financing Activities 12.2M USD
Net Cash Provided by (Used in) Investing Activities -3.78M USD -136%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 18.1M shares +4.33%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 27.1M USD -37.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 18.1M USD -36.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 59K USD
Deferred Tax Assets, Valuation Allowance 57.7M USD +0.4%
Deferred Tax Assets, Gross 104M USD -6.5%
Operating Lease, Liability 6.16M USD -44%
Payments to Acquire Property, Plant, and Equipment 105K USD -95.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 42.2M USD +54.7%
Lessee, Operating Lease, Liability, to be Paid 8.82M USD -42.7%
Property, Plant and Equipment, Gross 22.3M USD -1.53%
Operating Lease, Liability, Current 1.16M USD +70%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.19M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.05M USD -26.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +14.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.24M USD -48.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.23M USD -22.2%
Deferred Tax Assets, Operating Loss Carryforwards 45.7M USD -15.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 14.5M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.26M USD -22.3%
Additional Paid in Capital 239M USD +39.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 8.77M USD -7.73%
Deferred Tax Assets, Net of Valuation Allowance 46.1M USD -13.9%
Interest Expense 557K USD -55.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%